StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3029% above fair value
$515.02−5.64 (-1.08%)

Close on Nov 20, 2026Market cap $130.54BP/E 30.0Yield –

Vertex Pharmaceuticals Accounts receivable, net by Quarter

Accounts receivable, net ($M) ($M)

Vertex Pharmaceuticals Accounts receivable, net: $2,134M in Q2 2026, up 12.7% from a year earlier. That is the highest of the 67 quarters on record here.

Latest, Q2 2026
2,134
Period ended Jun 30, 2026
Change on a year earlier
+12.7%
1,894 in Q2 2025
History
67 quarters
Since Q4 2009
Sources
63
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-04) ↗

Reported in Form 10-Q / 10-K (DB).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAccounts receivable, net ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20262,134+12.7%Form 10-Q (filed 2026-08-04) ↗
Q1 2026Mar 31, 20261,996+10.6%Form 10-Q (filed 2026-05-05) ↗
Q4 2025Dec 31, 20252,053+27.6%Form 10-K (filed 2026-02-13) ↗
Q3 2025Sep 30, 20251,946+11.2%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 20251,894+14.3%Form 10-Q (filed 2025-08-05) ↗
Q1 2025Mar 31, 20251,805+0.7%Form 10-Q (filed 2025-05-06) ↗
Q4 2024Dec 31, 20241,609+2.9%Form 10-K (filed 2025-02-13) ↗
Q3 2024Sep 30, 20241,751+13.8%Form 10-Q (filed 2024-11-05) ↗
Q2 2024Jun 30, 20241,656+6.4%Form 10-Q (filed 2024-08-02) ↗
Q1 2024Mar 31, 20241,793+15.9%Form 10-Q (filed 2024-05-07) ↗
Q4 2023Dec 31, 20231,563+8.4%Form 10-K (filed 2024-02-15) ↗
Q3 2023Sep 30, 20231,539+11.1%Form 10-Q (filed 2023-11-07) ↗
Q2 2023Jun 30, 20231,556+16.8%Form 10-Q (filed 2023-08-02) ↗
Q1 2023Mar 31, 20231,548+19.7%Form 10-Q (filed 2023-05-02) ↗
Q4 2022Dec 31, 20221,442+26.9%Form 10-K (filed 2023-02-10) ↗
Q3 2022Sep 30, 20221,385+25.9%Form 10-Q (filed 2022-10-28) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Accounts receivable, net ($M), quarterly Q4 2009–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/fs-ar

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.

See a number that looks wrong?